American Association for Cancer Research
Journal
The mission of the American Association for Cancer Research is to prevent and cure cancer through research, education, communication, and collaboration. Through its programs and services, the AACR fosters research in cancer and related biomedical science; accelerates the dissemination of new research findings among scientists and others dedicated to the conquest of cancer; promotes science education and training; and advances the understanding of cancer etiology, prevention, diagnosis, and treatment throughout the world. Source
Actions
Media Outlet details
| Scope | National |
|---|---|
| Language | English |
| Country | United States of America |
Similarweb UVM
|
Request pricing |
Comscore UVM
|
Request pricing |
Recent Articles
Search ArticlesThe AACR Rare Cancers Initiative: Uniting Researchers, Undoing Barriers, and Unleashing Progress
Of all the challenges that cancer poses to human health, the confounding nature of rare cancers may be one of the most logistically difficult. The rarity of each rare cancer, considered individually, can make rigorous study difficult; however, considered as a collective, rare cancers threaten a substantial number of individuals by accounting for about 25% of all cancer cases.
From Treatment to Prevention: How Vaccines Are Reshaping the Fight Against Pancreatic Cancer
As one of the milestones of modern medicine, vaccination has been very effective at reducing the spread of infectious diseases. Drawing from this experience, researchers have been investigating ways to use vaccines as a form of immunotherapy to prevent and treat cancer by training the immune system to recognize and attack cancer cells. Read these previous posts for an introduction to cancer vaccines and some of the latest experimental strategies from the field.
A Vaccine to Prevent Pancreatic Cancer in High-risk Individuals Was Safe and Elicited Durable Immune Responses
PHILADELPHIA – A vaccine targeting common KRAS mutations was safe and stimulated KRAS-specific T-cell responses in 90% of study participants who were at high risk of developing pancreatic ductal adenocarcinoma (PDAC), according to phase I clinical trial results published in Cancer Discovery, a journal of the American Association for Cancer Research (AACR). PDAC is an aggressive cancer that is often diagnosed at advanced stages and carries a low five-year survival rate.
Catching the Drift: How Wildfire Smoke Plumes May Increase Cancer Risk
Inhaling smoke tends not to be good for you. Cigarette smoke, the classic airborne carcinogen, causes cancer directly, but other smoke sources like car traffic and diesel exhaust have also been associated with increased cancer risk. Perhaps it’s not surprising, then, that the smoke from wildfires may also be associated with cancer risk—and not just in the lungs.
Cancer Researchers Explain How OMB’s Proposed Changes to Federal Grantmaking Will Cause Delays, Reduce Transparency, and Undermine Merit-based Processes
Skip to Content Home > Cancer Research Catalyst > Cancer Researchers Explain How OMB’s Proposed Changes to Federal Grantmaking Will Cause Delays, Reduce Transparency, and Undermine Merit-based Processes Who should decide which scientific research projects deserve to be funded by the federal government? That question is at the heart of a proposed new set of regulations by the White House Office of Management and Budget (OMB).
Chris Baccash: A Brain Cancer Survivor Who Is Cycling to Make a Difference
Chris Baccash, a native of Doylestown, Pennsylvania, once dedicated his life to competitive cycling. As a founding member of the elite Doylestown Bike Works pro team, he spent years training, racing, and pushing his limits. In September 2019, he reached a major milestone, completing the 50-mile Bucks County Classic with his personal best result. But just months later, everything changed. After experiencing auditory hallucinations and a seizure, Baccash was diagnosed with , a form of brain cancer.
Men May Be More Likely Than Women to Receive Later-stage Diagnoses for Many Cancer Types in the United States
PHILADELPHIA – Between 2015 and 2022, men were more likely than women to be diagnosed with regional and/or distant stages of 20 nonreproductive solid cancer types in the United States, according to a study published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research (AACR). The study’s findings may provide insight into the discrepancies between men and women for cancer outcomes, the researchers noted.
From Discovery to Clinical Impact: AACR Special Conference Captured the Spectrum of Lymphoma Research
It’s a busy time in Philadelphia. In addition to semiquincentennial-related events and World Cup games, another crowd recently gathered in the city for the fifth Advances in Malignant Lymphoma: From Discovery to Clinical Impact conference, organized by the American Association for Cancer Research (AACR) in cooperation with the International Conference on Malignant Lymphoma.
FDA Approvals in Oncology: April-June 2026
Skip to Content Home > Cancer Research Catalyst > FDA Approvals in Oncology: April-June 2026 During the second quarter of 2026, oncology approvals issued by the U.S. Food and Drug Administration expanded the treatment options available for patients with breast cancer, urinary cancers, prostate cancer, rare cancers, and hematologic malignancies. Keep reading to learn about these approved therapeutics and how each fits into the treatment landscape of its respective cancer type.
AACR Statement and Call to Action Concerning OMB Proposal to Rewrite the Rules for Scientists and Physicians Who Are Improving Public Health and Saving Lives
PHILADELPHIA – The American Association for Cancer Research (AACR) is deeply concerned that the recent action of the White House Office of Management and Budget (OMB) to propose a new set of regulations on how federal grants are awarded and managed is a major threat to the National Institutes of Health (NIH) and its lifesaving mission to accelerate progress for patients with cancer and the hundreds of other diseases that afflict millions of Americans.